Taiwan Sees DNA Vaccine Patch On Market As Soon As Two Years
This article was originally published in PharmAsia News
Executive Summary
Taiwanese researchers say groundbreaking DNA vaccine patches they developed could be available to patients in two years if clinical tests and government approval move without a hitch. Instead of injections with needles or gene guns, the patches deliver the vaccine through the skin with a solution that allows the vaccine to unite with cells to produce antigens. The same team from two Taiwan institutions is attempting to develop the DNA vaccine patch to protect against Japanese encephalitis as well as other epidemic diseases. (Click here for more
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.